Vyro Bio
www.vyrobio.comVyro Bio is pioneering a novel class of tumor-directed oncolytic immunotherapies for malignant central nervous system (CNS) tumors, both pediatric and adult. Our focus is to revolutionize the treatment of these tumors through the development of oncolytic viruses (OVs) based on the properties of the Zika virus. A Vyro é pioneira em uma nova classe de imunoterapias direcionadas a tumores malignos do sistema nervoso central (SNC), tanto pediátricos quanto adultos. O foco é a revolução do tratamento desses tumores através do desenvolvimento de vírus oncolíticos baseados nas propriedades do Zika vírus.
Read moreVyro Bio is pioneering a novel class of tumor-directed oncolytic immunotherapies for malignant central nervous system (CNS) tumors, both pediatric and adult. Our focus is to revolutionize the treatment of these tumors through the development of oncolytic viruses (OVs) based on the properties of the Zika virus. A Vyro é pioneira em uma nova classe de imunoterapias direcionadas a tumores malignos do sistema nervoso central (SNC), tanto pediátricos quanto adultos. O foco é a revolução do tratamento desses tumores através do desenvolvimento de vírus oncolíticos baseados nas propriedades do Zika vírus.
Read moreCountry
City (Headquarters)
São Paulo
Industry
Employees
1-10
Founded
2021
Social
Employees statistics
View all employeesPotential Decision Makers
Chief Scientific Officer
Email ****** @****.comPhone (***) ****-****Board Member
Email ****** @****.comPhone (***) ****-****Member of the Scientific Advisory Board
Email ****** @****.comPhone (***) ****-****
Technologies
(6)